DNM1L and neoplasm: With a cut-off of 10.5, Drp1 could significantly detect tumor progression, but not overall survival (OS) (area under the curve (AUC), 0.710, 95.5% sensitivity, 48.1% specificity for tumor progression; AUC, 0.604, 90.0% sensitivity, 33.3% specificity for OS).